Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Adamas Pharmaceuticals Inc announces closing of initial public offering


Tuesday, 15 Apr 2014 04:00pm EDT 

Adamas Pharmaceuticals Inc:Closes initial public offering of 3,000,000 shares of common stock at public offering price of $16 per share.Shares began trading on NASDAQ Global Market under the ticker symbol ADMS on April 10.Adamas estimates net proceeds from offering to be about $41.5 mln after deducting underwriting discounts and commissions and estimated offering expenses.Credit Suisse and Piper Jaffray acted as joint book-running managers for the proposed offering.William Blair and Needham & Company acted as co-managers.